Biotech News

Stories

MorphoSys (MOR)MorphoSys2026-03-30 12:00 ESTClinical readout

Patient Perspectives

Mar 30, 2026

Managing Quality of Life with CML

How shared decision-making can support living well from the start with chronic myeloid leukemia

Patient Perspectives

Patient Perspectives

Mar 20, 2025

Marc’s story: Raising awareness of elevated Lp(a) in cardiovascular disease

Patient Perspectives

Patient Perspectives

Feb 13, 2024

Listening to the CML patient community

Improving the patient experience and removing potential barriers to clinical trial participation

Patient Perspectives

Patient Perspectives

Jan 25, 2024

Giving voice to people with a misunderstood disease

Shanelle Gabriel was diagnosed with lupus — a chronic autoimmune disease that mostly affects women of African American and Hispanic descent — while she was at college. Today, as a singer, poet and advocate, she uses her voice to highlight challenges faced by people living with this complex and often misunderstood condition.

Photos: Brent Stirton, Getty Images for Novartis

Patient Perspectives

Patient Perspectives

Jan 25, 2024

Facing the fear of breast cancer recurrence

When Laurie Brunner found a lump in her breast just before Thanksgiving in 2018, it was the beginning of one of the most difficult periods of her life. Although treatment put her cancer into remission, she found herself dealing with an emotional toll that affects many survivors of early-stage breast cancer: the fear of it coming back.

Photos: Brent Stirton, Getty Images for Novartis

Patient Perspectives

Patient Perspectives

Dec 2, 2023

Shoulder to shoulder

People with breast cancer need better medicines that help reduce the risk and anxiety of it returning.

Patient Perspectives

Patient Perspectives

May 4, 2023

Q&A: Addressing unmet needs for people living with PNH, a rare and chronic blood disorder

Hear from Director of Patient Services at AAMDSIF on how she supports patients with PNH, a blood disorder that significantly impacts quality of life.

Patient Perspectives

Patient Perspectives

Feb 2, 2023

When you think of the word ‘cancer’, what are the first words that spring to mind?

Fighter. Hero. Cancer-stricken. The words and metaphors people use to talk about cancer often feel worlds apart from any other disease. But how far does it go? Do words matter?

Patient Perspectives

Patient Perspectives

Jan 25, 2024

A cancer patient gets a new lease on life

After being diagnosed with advanced prostate cancer, Van Lacour received a Novartis radioligand therapy as part of a managed access program in 2021. Today, he is living a fulfilling life in his hometown of Natchez, Louisiana, US.

Patient Perspectives

Patient Perspectives

Oct 28, 2022

Prostate cancer and support of the care partner – Carl and Arlene’s story

When Carl was diagnosed with metastatic prostate cancer, he and his wife Arlene began navigating his cancer journey while still looking to enjoy their retirement – hoping to remain active with family and friends in their retirement community.

Patient Perspectives

Patient Perspectives

Oct 6, 2022

Let’s Talk About the C Word: Navigating a cancer diagnosis and the life beyond it with Leanne Pero

Leanne Pero discusses her experiences of life before, during and after breast cancer, and how it inspired her to advocate for herself and others like her.

Patient Perspectives

Patient Perspectives

Mar 21, 2022

Understanding hidradenitis suppurativa through Jasmine’s eyes

Patient Perspectives

Open original release

Related news

MORMorphoSys2026-07-17 12:00 EST

Novartis Fabhalta® (iptacopan) receives FDA traditional approval as first and only complement inhibitor to significantly slow kidney function decline in primary IgAN

MORMorphoSys2026-07-06 12:00 EST

Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients

INBXInhibrx2026-07-16 13:00 EST

Inhibrx Announces Amended Loan Agreement with Oxford Finance, Expanding Total Facility to $500.0 Million

ARTLArtelo Biosciences2026-07-16 12:48 EST

Artelo Biosciences Announces Results from a Nonclinical Osteoarthritis Study Supporting ART26.12 as a Potential First-in-Class New Therapy for Chronic Pain Conditions

MRKMerck2026-07-16 12:31 EST

Merck’s LIPFENDRA® (enlicitide) is the First and Only Once-Daily Oral PCSK9 Inhibitor Approved by the U.S. FDA to Reduce LDL-C in Adults with Hypercholesterolemia

INGNInogen2026-07-16 12:30 EST

Inogen to Report Second Quarter 2026 Financial Results on August 6, 2026

ALNYAlnylam Pharmaceuticals, Inc.2026-07-16 12:00 EST

Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results

VRAXVirax Biolabs2026-07-16 11:30 EST

Virax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply Agreement

GLSIGreenwich LifeSciences2026-07-16 11:30 EST

Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01

RLMDRelmada2026-07-16 11:05 EST

Relmada Therapeutics to Report Second Quarter 2026 Financial Results on Thursday, August 6, 2026

MorphoSys

MorphoSys is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.

Recent company news

Stock data

Close
18.96 USD
Market cap
Exchange
NASDAQ
Sector
Biotechnology
Location
United States